CNBC
US · 4 hrs ago
Weight loss drug maker sinks 25% after new safety data spooks investors
—Quality
0Ratings
0Comments
Weight loss drug maker sinks 25% after new safety data spooks investors
While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!